diabetes

Diabetes drug gets FDA nod, but who'll sell it?
Fierce Pharma
Thu, 05/7/09 - 08:38 pm
FDA
Onglyza
diabetes
Cycloset
VeroScience
Is Amylin caving to proxy pressure?
Fierce Pharma
Thu, 05/7/09 - 10:30 am
Amylin
diabetes
Amylin Seeks FDA Approval on Extended Byetta Treatment
WSJ Online
Tue, 05/5/09 - 10:35 am
Amylin
FDA
Byetta
diabetes
Amylin and Lilly partner to develop new pen device for diabetes therapy
Pharmaceutical Business Review
Fri, 05/1/09 - 10:45 am
diabetes
Amylin
Eli Lilly
partnerships
exanitide
Novo Nordisk postpones pre-launch physician training for liraglutide
FT.com
Tue, 04/28/09 - 08:41 am
Novo Nordisk
Victoza
diabetes
FDA Extends Bristol Diabetes Drug Deadline
TheStreet.com
Fri, 04/24/09 - 06:12 am
FDA
diabetes
Bristol-Myers Squibb
Onglyza
FDA Calendar Updates: Diabetes
Seeking Alpha
Thu, 04/23/09 - 09:49 am
FDA
diabetes
Bristol-Myers Squibb
AstraZeneca
Onglyza
alogliptin
Takeda
Novo Nordisk
Victoza
Pay for Performance for Prescription Drugs (Or Maybe Not)
WSJ Online
Thu, 04/23/09 - 09:24 am
Januvia
Cigna
Merck
diabetes
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thu, 04/23/09 - 08:30 am
Bristol-Myers Squibb
FDA
AstraZeneca
Onglyza
diabetes
Amylin: A Discounted Option on Byetta's Outcome
Seeking Alpha
Wed, 04/22/09 - 11:25 am
Amylin
diabetes
Byetta
Being Second In Line No Hurdle In Pharma
Yahoo/Investors Business Daily
Fri, 04/10/09 - 08:30 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Onglyza
Merck
Januvia
Amylin's Pullback Is Unjustified
Seeking Alpha
Fri, 04/10/09 - 08:28 am
Amylin
Byetta
diabetes
Amylin Staunchly Defends Byetta
TheStreet.com
Tue, 04/7/09 - 11:19 am
Amylin
diabetes
Byetta
Experts: Unknown tumor risk for Novo diabetes drug
Yahoo/AP
Fri, 04/3/09 - 07:35 am
cancer
diabetes
Novo Nordisk
liraglutide
Bristol-Myers climbs in pre-market trade on FDA nod
Marketwatch
Thu, 04/2/09 - 09:36 am
FDA
Bristol-Myers Squibb
diabetes
Onglyza
AstraZeneca
Which Diabetes Drugs Will Win Out?
Seeking Alpha
Thu, 04/2/09 - 06:14 am
diabetes
Alkermes
Eli Lilly
Amylin
AstraZeneca
Bristol-Myers Squibb
GSK
Takeda
Merck
Novo Nordisk
FDA meeting on Bristol-Myers Squibb diabetes drug has implications for industry
Yahoo/AP
Wed, 04/1/09 - 07:17 am
FDA
diabetes
Bristol-Myers Squibb
Onglyza
GSK
AstraZeneca
Amylin rises, Novo falls on diabetes developments
Yahoo/AP
Tue, 03/31/09 - 12:53 pm
Amylin
diabetes
Novo Nordisk
exanitide
Byetta
FDA: Bristol-Myers diabetes drug appears safe
Yahoo/AP
Mon, 03/30/09 - 11:04 am
FDA
Bristol-Myers Squibb
diabetes
Onglyza
AstraZeneca
Drug maker leads diabetes race: Novo Nordisk says U.S. hasn't asked for more tests; AZ, Bristol-Myers aren't so lucky
The News Journal,DE
Sun, 03/29/09 - 10:52 am
Novo Nordisk
AstraZeneca
Bristol-Myers Squibb
diabetes

Pages